| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/14/2013 | US20130039935 Induction of tumor immunity by variants of folate binding protein |
| 02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
| 02/14/2013 | CA2843665A1 Anti-il-6 vaccine composition |
| 02/13/2013 | EP2557088A1 Physiologically active peptides |
| 02/13/2013 | EP2556084A1 Cdca5 peptides and vaccines including the same |
| 02/13/2013 | CN1953988B Peptides derived from human BPLP protein, polynucleotides coding for the peptides and antibodies directed against the peptides |
| 02/13/2013 | CN102933224A Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924577A Chicken high mobility group protein B1 (chHMGB1) antigen polypeptide and anti-chHMGB1 monoclonal antibody |
| 02/13/2013 | CN102924576A Helicobacter pylori immunodominance epitope peptide and preparation method and application thereof |
| 02/13/2013 | CN102924575A Preparation method of bivalirudin |
| 02/13/2013 | CN102924574A Antibacterial peptide LZ1 and application of antibacterial peptide in preparation of antibacterial medicament |
| 02/13/2013 | CN102924573A Actin binding peptide and purpose thereof |
| 02/13/2013 | CN102924572A Method for preparing high-purity daptomycin |
| 02/13/2013 | CN102924571A Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof |
| 02/13/2013 | CN102924570A Fluorescence labeling peptide, as well as preparation method and application thereof |
| 02/13/2013 | CN102924569A Liquid phase synthesis method of eptifibatide |
| 02/13/2013 | CN102268068B Substrate metal prolease-9 polypeptide inhibitor 1and application thereof |
| 02/13/2013 | CN102250220B Preparation method of colistin sulphate |
| 02/13/2013 | CN101870726B Peptide - cisplatin conjugate and preparation method and application thereof |
| 02/13/2013 | CN101693738B Method for synthesizing terlipressin by solid-phase oxidization and cyclization |
| 02/12/2013 | US8372959 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 02/12/2013 | US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 02/12/2013 | US8372951 Cell penetrating peptides for intracellular delivery |
| 02/12/2013 | US8372950 IgG binding peptide |
| 02/12/2013 | US8372406 Antitumoral and antiviral peptides |
| 02/12/2013 | CA2493471C Compounds binding to p-selectin |
| 02/12/2013 | CA2461740C Synthesis of cyclosporin analogs |
| 02/07/2013 | WO2013019445A2 Anti-angiogenic peptides and uses thereof |
| 02/07/2013 | WO2013016810A1 Organelle targeting nanocarriers |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/07/2013 | US20130035291 Obtainment of bioactive products from cocoa having inhibitory activity against the pep enzyme and antioxidant and/or antineurodegenerative activity |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035245 Inorganic-binding peptides and quality control methods using them |
| 02/07/2013 | US20130034575 Method for identification, isolation and production of antigens to a specific pathogen |
| 02/07/2013 | US20130034574 Modified melk peptides and vaccines containing the same |
| 02/07/2013 | US20130034561 Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2013 | CA2842722A1 Organelle targeting nanocarriers |
| 02/06/2013 | EP2554180A1 Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 02/06/2013 | EP2553096A1 Ect2 peptides and vaccines including the same |
| 02/06/2013 | EP2552941A1 Purification of caspofungin intermediates |
| 02/06/2013 | EP2552940A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | EP2552939A1 Rfamide-related peptides and methods thereof |
| 02/06/2013 | EP2552938A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 02/06/2013 | EP2552937A1 A process for purification of pneumocandin |
| 02/06/2013 | EP2552470A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | EP2552462A2 Ccn3 peptides and analogs thereof for therapeutic use |
| 02/06/2013 | EP2514761A9 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 02/06/2013 | CN102917724A Pea protein peptides with anti helicobacter pylori activity |
| 02/06/2013 | CN102911988A Preparation method of broad spectrum antimicrobial peptide |
| 02/06/2013 | CN102911257A Cyclic lipopeptide antibiotic and preparation and application thereof |
| 02/06/2013 | CN102911255A Preparation method of 18F marker containing 1,4-disubstituted triazole structure |
| 02/06/2013 | CN102295684B Insulin chain A human leukocyte antigen (HLA)-A*0201 restrictive cytotoxic T lymphocyte (CTL) epitope altered peptide ligand and application thereof |
| 02/06/2013 | CN102250214B Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy |
| 02/06/2013 | CN102160890B Pharmaceutical composition comprising an analgesic peptide |
| 02/05/2013 | US8367801 Proteinaceous compounds |
| 02/05/2013 | US8367620 Peptidic growth hormone secretagogues analog compounds and preparations thereof |
| 02/05/2013 | US8367607 Oxyntomodulin peptide analogue |
| 02/05/2013 | US8367355 Method of quantitative assessment on reproductive effort of black-lip pearl oysters using antibody specific thereto |
| 02/05/2013 | CA2515975C Peptide derivatives having .beta.-secretase inhibitory activity |
| 02/05/2013 | CA2352454C Peptide-based vaccine for influenza |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 01/31/2013 | WO2013015241A1 Fire extinguishing agent and fire extinguishing method using same |
| 01/31/2013 | WO2013014527A1 Processes for preparing eptifibatide |
| 01/31/2013 | WO2012170804A9 Treatments for gastrointestinal disorders |
| 01/31/2013 | US20130030150 Purification Method of Azacyclohexapeptide or Its Salt |
| 01/31/2013 | US20130029921 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof |
| 01/31/2013 | US20130029907 Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof |
| 01/31/2013 | US20130029903 Azuvirin Peptides |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130029358 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| 01/31/2013 | US20130028923 Kdr peptides and vaccines comprising the same |
| 01/31/2013 | US20130028922 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/31/2013 | CA2842583A1 Fire extinguishing agent and fire extinguishing method using same |
| 01/30/2013 | EP2550291A1 Salt-resistant emulsions |
| 01/30/2013 | CN102906105A Compounds and their use |
| 01/30/2013 | CN102905721A Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 01/30/2013 | CN102898510A Method for separating enramycin A from enramycin B |
| 01/30/2013 | CN102898509A Method for preparing enramycin crude product |
| 01/30/2013 | CN102898508A Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application |
| 01/30/2013 | CN102898507A Thrombolysis oligopeptide-imidazolidine binary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898506A RPAK/imidazolidine/RGD ternary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898505A ARPAK/imidazolidine/RGD ternary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102304170B Horn polypeptide, and separation method and antioxidation application thereof |
| 01/30/2013 | CN102250212B Matrix metalloproteinase-9 polypeptide inhibitor 5 and use thereof |
| 01/30/2013 | CN102180949B Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 01/30/2013 | CN102070702B A beta 1-10 specific binding peptide and screening method thereof |
| 01/30/2013 | CN101432295B Application of peptide from lactoprotein |
| 01/29/2013 | US8362203 Non-natural peptides as models for the development of antibiotics |
| 01/29/2013 | US8361970 Growth factor binding molecules |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361740 Peptide standards |
| 01/29/2013 | US8361479 Promiscuous PAP CD4 T cell epitopes |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | CA2482995C Low-cost production of peptides |
| 01/24/2013 | WO2013013075A2 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 01/24/2013 | WO2013011056A2 Pathology biomarker assay |
| 01/24/2013 | WO2013010254A1 Biomarkers for ankylosing spondylitis |
| 01/24/2013 | US20130023644 Beta-amino acids |
| 01/24/2013 | US20130023643 Nuclear localization signal peptides derived from vp2 protein of chicken anemia virus and uses of said peptides |